Inequities in academic research are manifested in many different ways: from the low proportion of women who are tenured professors, to the low rates of grants awarded to women and researchers who are members of underrepresented racial & ethnic groups in research, to the lack of appropriate sex and gender-based analysis in research studies.
As a global leader in research information & analytics and scientific publishing, Elsevier can make an impact in key areas to enhance diversity and inclusion in research across gender, race & ethnicity, and geographical dimensions and ensure that research is conducted and reported in the most equitable and inclusive manner possible.
Knowledge and innovation are born of diversity: diversity of people, ideas, thought, culture and perspective. We are committed to ensuring that everyone has an equal opportunity to succeed and to driving that in research, in health, and in our own organization.
Through the creation of an Inclusion & Diversity Advisory Board, we resolve to:
- Work with research leaders, funding bodies and higher education institutions to drive gender and racial & ethnic equity across the STEM academic career path
- Work with academics, publishers, and funders to promote greater gender and racial & ethnic diversity and inclusion as well as geographic representation in editorial boards, peer review and scientific conferences while supporting publication and inclusive participation in research
- Promote inclusion and diversity best practices to help foster diverse and inclusive future generations of STEM graduates
- Encourage enhanced sex and gender-based analysis and reporting in research studies
- Work with our network of stakeholders to influence and address inequality in the communities we serve
- Publish an annual report to highlight areas of progress and summarize the actions of the I&D Advisory Board
The future of science depends on a robust and diverse workforce drawn from all corners of society. Our partnerships focus on fostering inclusive policy and advancing women scientists in developing countries.
Working toward racial and social equality: free access to curated research related to systemic racism, healthcare bias, racial violence, law enforcement reform and social justice movements.
Since 2005, the Elsevier Foundation works in partnership with knowledge-centered institutions around the world, supporting innovations for inclusive health and research.
Discover the RELX SDG Resource Centre, showcasing the latest in science, law, business, events and more that can help drive forward the SDGs.
Read more about how we contribute to a more inclusive research ecosystem:
- We must make progress across all dimensions of diversity. Kumsal Bayazit, CEO, October 9, 2020
- 4 ways we can support racial equality as publishers, Rachel Martin, October 7, 2020
- The importance of sex and gender reporting, Jessica Miles, August 20, 2020
- Elsevier condemns racisms ad discrimination: Committed to inclusion and equity, we stand in solidarity with Black communities - because Black Lives Matter, Kumsal Bayazit, CEO, August 12, 2020
- Applying “gender lens” can help us achieve better health and disaster responses Domiziana Francescon and Yuri Ishizaki, August 4, 2020
The mission of the Board is to create a more equitable research ecosystem by:
- Drive I&D initiatives that lead to positive change in gender and race & ethnicity diversity and inclusion and geographic representation in academic research.
- Help set standards and best practices that drive unbiased, robust decisions incorporating I&D principles in research.
- Influence and improve gender and racial & ethnic diversity and inclusion and geographic representation in research funding, editorial boards, peer review and scientific conferences and ensure that research is conducted and reported in the most equitable and inclusive manner possible.
Kumsal Bayazit was appointed Chief Executive Officer of Elsevier in February 2019. She has held multiple positions with RELX since 2004, most recently as Regional President Europe, Middle East and Africa at Reed Exhibitions.
View full bio
Before joining Reed Exhibitions in 2016, Kumsal was RELX Chief Strategy Officer, responsible for driving strategic initiatives, technology strategy and portfolio management. Prior to that she served in several operational and strategic roles with LexisNexis. Kumsal also chairs the Technology Forum at RELX. Prior to joining RELX Group in 2004, Kumsal spent several years at Bain & Company in their New York, Los Angeles, Johannesburg and Sydney offices. Kumsal earned an MBA from Harvard Business School and is a graduate of University of California at Berkeley where she received a Bachelor’s degree in Economics with honors.
Richard Horton is Editor-in-Chief of The Lancet. He qualified in physiology and medicine with honours from the University of Birmingham in 1986. He joined The Lancet in 1990, moving to New York as North American Editor in 1993. Richard was the first President of the World Association of Medical Editors and he is a Past-President of the US Council of Science Editors. He is an honorary professor at the London School of Hygiene & Tropical Medicine, University College London, and the University of Oslo.
View full bio
He has received honorary doctorates in medicine from the University of Birmingham, UK, and the Universities of Gothenburg and Umea in Sweden. In 2016, he was appointed to the High-Level Working Group for the Health and Human Rights of Women, Children, and Adolescents. In 2016, he also chaired the Expert Group for the High Level Commission on Health Employment and Economic Growth, convened by Presidents Hollande of France and Zuma of South Africa. From 2011 to 2015, he was co-chair of the UN's independent Expert Review Group on Information and Accountability for Women's and Children's Health. Richard received the Edinburgh Medal in 2007 and the Dean’s Medal from Johns Hopkins School of Public Health in 2009. In 2016, he was awarded an Honorary Fellowship by the British Pharmacological Society. He has written two reports for the Royal College of Physicians of London: Doctors in Society (2005) and Innovating for Health (2009). He wrote Health Wars (2003) about contemporary issues in medicine and health, and he has written for The New York Review of Books and the TLS. He has a strong interest in global health and medicine’s contribution to our wider culture. He now works to develop the idea of planetary health – the health of human civilizations and the ecosystems on which they depend. In 2011, he was elected a Foreign Associate of the US Institute of Medicine. In 2015, he received the Friendship Award from the Government of China. In 2016, he received the Andrija Stamper medal from the Association of Schools of Public Health in the European region and in 2017, he was awarded the Edwin Chadwick Medal for outstanding contributions to the advancement of public health.
Gary L. Darmstadt
Gary L. Darmstadt, MD, MS, is Associate Dean for Maternal and Child Health, and Professor of Neonatal and Developmental Medicine in the Department of Pediatrics at the Stanford University School of Medicine. From 2015-2019 he chaired the Steering Committee of The Lancet Series on Gender Equality, Norms and Health. Previously Dr. Darmstadt was Senior Fellow in the Global Development Program at the Bill & Melinda Gates Foundation (BMGF), where he led cross-foundation initiatives on Women, Girls and Gender.
View full bio
Prior to this role, he served as BMGF Director of Family Health, leading strategy development and implementation across nutrition, family planning and maternal, newborn and child health. Darmstadt was formerly Associate Professor and Founding Director of the International Center for Advancing Neonatal Health in the Department of International Health at the Johns Hopkins School of Public Health. He has trained in Pediatrics at Johns Hopkins University, in Dermatology at Stanford University, and in Pediatric Infectious Disease as a fellow at the University of Washington, Seattle, where he was Assistant Professor in the Departments of Pediatrics and Medicine. Dr. Darmstadt also served as Senior Research Advisor for the Saving Newborn Lives program of Save the Children-US, where he led the development and implementation of the global research strategy for newborn health and survival.
University College London
Sarah Hawkes is the Director of the Centre for Gender and Global Health, and a medical doctor with a degree in sociology and a PhD in epidemiology. She is Professor of Global Public Health at University College London where she leads a research theme analysing the use of evidence in policy processes, particularly in relation to gender and health, and sexual health. Sarah is co-founder and co-Director of Global Health 50/50, an independent initiative that works to advance action and accountability for gender equality in global health.
View full bio
She has lived and worked for much of the past 25 years in Asia, where she has gathered evidence, collaborated to strengthen capacity, and operated at the interface of policy and research communities – working alongside national Governments, UN agencies and civil society organisations promoting gender, equity, equality and human rights in health policies and programmes.
National University of Singapore
Helena Legido-Quigley is an Associate Professor at the Saw Swee Hock School of Public Health and has a parallel position with the London School of Hygiene and Tropical Medicine. She is also an Associate Fellow at Chatham House, the Royal Institute of International Affairs.
View full bio
She has conducted research on health policy and health systems in Europe, Sub-Saharan Africa and currently with a focus on Southeast Asia. Specific areas of expertise include gender equality, migrant health, global health governance, and health systems resilience. Specific research with a gender lens includes studies on gender equality in global health, gender and ethnic diversity in leading public health universities, gender equality and leadership in the nursing profession, and gender differences in the utilization of services. She has published over 100 articles in peer reviewed journals. Her work has been published in journals such as the Lancet, British Medical Journal and PLOS Medicine. It has also been widely covered in International media including The Times, The Economist, the Financial Times and the Huffington Post.
Elizabeth Pollitzer, PhD
Dr. Elizabeth Pollitzer holds PhD in Information Science from London University. Her original science training was in Biophysics at Kings College University of London, where she was introduced to social responsibility of science through a course set up by Maurice Wilkins, which influenced her subsequent career plans.
View full bio
She moved to Imperial College University of London, first to the School of Management and then to the Department of Computing, where she spent over 20 years as researcher and lecturer. In 2001 together with a group of women scientists and engineers at Imperial College she set up Portia a not-for-profit organisation focused on improving gender equality in science practice and integration of gender dimension in science knowledge. She coordinated a number of European and international projects, notably the UK Tri-Council Initiative on Cognitive Science and Human-Computer Interactions; the FP7 funded genSET project; and two projects dedicated to women’s early science career stage issues, one funded by the Elsevier Foundation and the other by the Robert Bosch Foundation. She acts as expert adviser to the European Commission, and was involved in several European projects: GenPORT, GENERA, NAPES, and currently in ACT. She is also responsible for the coordination, organization, and global development of the Gender Summit platform, which brings scientists, gender scholars and policy makers together to examine research evidence showing the influence of sex-gender factors in research results and in outcomes for women and men, and establish consensus on where improvements are needed and what actions will achieve change.
Londa Schiebinger, PhD
Dr. Londa Schiebinger is the John L. Hinds Professor of History of Science in the History Department at Stanford University and Director of the EU/US Gendered Innovations in Science, Health & Medicine, Engineering, and Environment Project. From 2004-2010, Schiebinger served as the Director of Stanford's Clayman Institute for Gender Research. She is a member of the American Academy of Arts and Sciences.
View full bio
Prof. Schiebinger received her PhD from Harvard University in 1984 and is a leading international authority on gender and science. Over the past 30 years, Dr. Schiebinger's work has been devoted to teasing apart three analytically distinct but interlocking pieces of the gender and science puzzle: the history of women's participation in science; gender in the structure of scientific institutions; and the gendering of human knowledge.
Dr. Schiebinger presented the keynote address and wrote the conceptual background paper for the United Nations' Expert Group Meeting on Gender, Science, and Technology, September 2010 in Paris. She presented the finding at the United Nations in New York, February 2011 with an update spring 2014. In 2011-2012 and 2018-2020, Dr. Schiebinger entered into major collaborations with the European Union to promote Gendered Innovations in Science, Health & Medicine, Engineering, and Environment. This project draws experts from across the US, Europe, Canada, Asia and now Latin America and was presented at the European Parliament in July 2013.
Martina Schraudner, PhD
Technical University of Berlin & Fraunhofer Center for Responsible Research and Innovation
Prof Dr Martina Schraudner is a Professor of Gender and Diversity in Technology and Product Development at the Technical University of Berlin and head of Fraunhofer Center for Responsible Research and Innovation. In addition, Martina Schraudner is a Board Member of Acatech, Head of the Department of Gender and Diversity in Organizations at Technical University Berlin, and Director of Responsible Research and Innovation Unit at Fraunhofer Gesellschaft.
View full bio
Her research currently focuses on the integration of different perspectives in the innovation process and involvement of potential users, dialogue between different science disciplines, and accommodating views of different stakeholders. Prof. Schraudner is a member of the genSET Science Leaders Panel; the Gender Summits were established on the recommendation of the panel.
Hannah Valantine, MD
Hannah Valantine recently returned to Stanford as Professor of Medicine having served for six years as the inaugural NIH Chief Officer for Scientific Workforce Diversity, and a Senior Investigator in the Intramural Research Program at the National Heart, Lung, and Blood Institute (NHLBI). Prior to starting this position in April 2014, Dr. Valantine was Professor of Cardiovascular Medicine and the Senior Associate Dean for Diversity and Leadership at Stanford, a leadership position she held since November 2004. She is nationally recognized for her transformative approaches to diversity and is a recipient of the NIH Director’s Pathfinder Award for Diversity in the Scientific Workforce.
View full bio
Citing NIH Director Dr. Francis Collins’ statement about Dr. Valantine’s accomplishments at NIH, “her laser-like focus on expanding recruitment and retention of the brightest minds regardless of race, ethnicity, gender, disability, and socioeconomic status has produced remarkable results over a few short years.” For example, she established the Distinguished Scholars Program, which has had a dramatic, positive impact on the diversity of tenure-track investigators at NIH. Hannah established the NIH Equity Committee to systematically track and evaluate diversity and inclusion metrics in each NIH Institute and Center’s intramural program. Under her leadership, there has been a significant increase in representation of women as tenure-track and tenured principal investigators (PI), and of African American/Black and Hispanic tenure-track PIs in the Intramural Program. There also has been a significant increase in representation of women in NIH leadership positions, such as Institute/Center Directors and Scientific Directors. she played a major role in taking on workplace harassment at NIH. One of her significant achievements was developing and implementing the first NIH Workplace Climate and Harassment Survey. The findings provided critical data that have informed NIH’s strategies to improve the workplace moving forward. The survey provides a tool (now published) for NIH-funded institutions across the country to assess and improve their workplace climates.
The impact of Dr. Valantine’s work has been felt well beyond the NIH campus. She has made several important inroads into improving diversity and equity among the extramural research community. For example, Hannah designed the Faculty Institutional Recruitment for Sustainable Transformation (FIRST) program that is being implemented by the NIH Common Fund to create cultures of inclusive excellence at NIH-funded institutions. She also guided the National Research Mentoring Network program on coaching and mentoring for grant writing toward successful applications and awards supporting scientists from diverse backgrounds, including those from underrepresented racial and ethnic groups. Since her arrival at NIH, there has been a significant increase in the number of R01 applications and awards that identify African American/Black and Hispanic scientists as the Program Director/Principal Investigator (PD/PI). And for early career scientists, she has focused on career development awards (K-series), the penultimate stage before R01 grants, increasing the number of applications and awards on which African American/Black and Hispanic scientists are identified as PD/PIs, essentially eliminating the racial gap in success rates for K-awards.
At NIH Dr. Valantine established a highly productive research program within the National Heart, Lung, and Blood Institute (NHLBI). She created the Genomic Research Alliance for Transplantation (GRAfT), a consortium of five heart and lung transplant programs in the Washington, D.C. metropolitan area, which has enrolled and is actively following more than 500 patients, 40% of whom are African American/Black. She is using the technology that she co-invented with Steve Quake, professor bioengineering at Stanford — donor-derived cell-free DNA in blood — to monitor organ transplant rejection in the GRAfT cohort, and to understand the mechanisms that explain how and why African Americans/Blacks reject their organ transplants at higher rates than White recipients.
Dr. Valantine was elected to National Academy of Medicine in 2020, “for her national leadership in both scientific workforce diversity and cardiac transplantation research. Her data-driven approach in these two important areas has led to game-changing policies and new programs that enriched the nation’s biomedical talent pool and have generated paradigm-shifting innovations in patient care.”
Miyoko O. Watanabe, PhD
Japan Science and Technology Agency
Dr. Miyoko O. Watanabe serves at Japan Science and Technology Agency (JST) as Executive Director and Director of Office for Diversity and Inclusiveness. She has a long experience of research in semiconductor physics at Toshiba R&D Center in Japan, and she conducted her physics research as a Postdoctoral Fellow at Dalhousie University, Canada, from 1986 to 1988 and as a Visiting Researcher at Nanoscale Physics Research Laboratory at the University of Birmingham, U.K., in 1997. Returning to Toshiba, she served there at different positions, including that of Executive Quality Leader at Innovation Division in the headquarters. She has been working at JST since 2013.
View full bio
She also worked as Council Member of Science and Technology Council at Ministry of Education, Culture, Sports, Science and Technology from 2012 to 2017, as Chairperson of Japan Women Engineers Forum from 2012 to 2014, and as Auditor at National Institute for Environmental Studies in Japan from 2013 to 2015.
She has also been Council Member of Science Council of Japan (SCJ) since 2011, and Vice-president of SCJ in charge of science and society since October 2017. She worked as Chair of Committee on Comprehensive and Synthetic Engineering in SCJ from 2014 to 2017. Dr. Watanabe has been a member of Specialist Committee on Priority Policy in Council for Gender Equality of Cabinet Office of Japan since 2014. She was the chair of both Science Agora in 2015 and 2016 and Gender Summit 10 in Tokyo in 2017. She was also appointed STEM girls ambassador by Cabinet office in June, 2018, and has been active to promote STEM girls activity.
Tom Welton, OBE, CChem, FRSC, FCGI
Imperial College London
Prof. Tom Welton is currently the President-Elect of the Royal Society of Chemistry and will take up the full role in June 2020. He joined Imperial in 1993 and served as Head of the Department of Chemistry from 2007 to 2014, before becoming Dean of the Faculty of Natural Sciences until December 2019. He is a Fellow and a member of the Council of the Royal Society of Chemistry. He will continue to be a member of the Imperial community while taking up his new position as RSC president.
View full bio
Welton's research focuses on sustainable chemistry, and involves ionic liquids – chemicals that provide hope for replacing solvents that are used to dissolve materials but are often hazardous to health and the environment. As well as studying how they behave, he works on practical applications of future ionic liquid solvents, such as for dissolving textiles to make them more readily recyclable and for dissolving wood to create biofuels.
Under Professor Welton’s leadership as Head of Chemistry at Imperial, the department was awarded an Athena SWAN Gold Award in recognition of efforts to promote women in science – one of only four awarded in the country at the time. He has also been appointed to the UKRI Equality, Diversity and Inclusion External Advisory Group and in 2017 was awarded an OBE for services to diversity in education.
Dr. Nieng Yan received her BS degree from the Department of Biological Sciences & Biotechnology, Tsinghua University, Beijing, China, in 2000. She then pursued her PhD in the Department of Molecular Biology at Princeton University under the supervision of Prof. Yigong Shi between 2000 and 2004. She was the regional winner of the Young Scientist Award (North America) co-sponsored by Science/AAAS and GE Healthcare in 2005 for her thesis on the structural and mechanistic study of programmed cell death.
View full bio
She continued her postdoctoral training at Princeton University, focusing on the structural characterization of intramembrane proteases. In 2007, she joined the faculty of School of Medicine, Tsinghua University. Her lab has been mainly focusing on the structural and functional study of membrane transport proteins exemplified by the glucose transporters and Na+/Ca2+ channels. In 2012 and 2013, she was promoted to tenured professor and Bayer Endowed Chair Professor, respectively. Dr. Yan was an HHMI international early career scientist in 2012-2017, the recipient of the 2015 Protein Society Young Investigator Award and the 2015 Beverley & Raymond Sackler International Prize in Biophysics, and the Alexander M. Cruickshank lecturer at the GRC on membrane transport proteins in 2016.